The ExcellMater project: Advancing biomaterials engineering towards novel medical devices Abstract
Article Sidebar
Main Article Content
Abstract
The route of novel biomaterials from synthesis to utilization in medical devices and products is complex requiring comprehensive physico-chemical, biological and functional characterization of biomaterials followed by preclinical and clinical studies adhering to strict procedures and regulations. Faculty of Technology and Metallurgy (FTM) in Belgrade is one of the leading institutions in Serbia in the field of materials engineering including certain areas in biomaterials engineering. Various biomaterials with bioactive agents were synthesized by variety of methods and characterized in detail regarding composition, morphology, structure, and mechanical and thermal properties. However, the next phases towards translation to medical devices and products are lacking primarily due to the lack of knowledge in these fields. The aim of the project “Twinning to excel materials engineering for medical devices – ExcellMater” funded by the European Union’s Horizon 2020 research and innovation programme is to tackle this weakness by twinning the needed expertise to FTM from the international project partners: University of Eastern Piedmont, Italy, AO Research Institute Davos, Switzerland, and Aalto University, Finland.
Article Details
Section
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors grant to the Publisher the following rights to the manuscript, including any supplemental material, and any parts, extracts or elements thereof:
- the right to reproduce and distribute the Manuscript in printed form, including print-on-demand;
- the right to produce prepublications, reprints, and special editions of the Manuscript;
- the right to translate the Manuscript into other languages;
- the right to reproduce the Manuscript using photomechanical or similar means including, but not limited to photocopy, and the right to distribute these reproductions;
- the right to reproduce and distribute the Manuscript electronically or optically on any and all data carriers or storage media – especially in machine readable/digitalized form on data carriers such as hard drive, CD-Rom, DVD, Blu-ray Disc (BD), Mini-Disk, data tape – and the right to reproduce and distribute the Article via these data carriers;
- the right to store the Manuscript in databases, including online databases, and the right of transmission of the Manuscript in all technical systems and modes;
- the right to make the Manuscript available to the public or to closed user groups on individual demand, for use on monitors or other readers (including e-books), and in printable form for the user, either via the internet, other online services, or via internal or external networks.
How to Cite
Funding data
-
Horizon 2020
Grant numbers 952033
References
https://excellmater.tmf.bg.ac.rs/ Accessed February 20, 2024